1. Home
  2. PTGX vs TNET Comparison

PTGX vs TNET Comparison

Compare PTGX & TNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • TNET
  • Stock Information
  • Founded
  • PTGX 2006
  • TNET 1988
  • Country
  • PTGX United States
  • TNET United States
  • Employees
  • PTGX 130
  • TNET N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • TNET Business Services
  • Sector
  • PTGX Health Care
  • TNET Consumer Discretionary
  • Exchange
  • PTGX Nasdaq
  • TNET Nasdaq
  • Market Cap
  • PTGX 5.0B
  • TNET 3.0B
  • IPO Year
  • PTGX 2016
  • TNET 2014
  • Fundamental
  • Price
  • PTGX $79.54
  • TNET $55.30
  • Analyst Decision
  • PTGX Strong Buy
  • TNET Hold
  • Analyst Count
  • PTGX 9
  • TNET 4
  • Target Price
  • PTGX $86.22
  • TNET $77.33
  • AVG Volume (30 Days)
  • PTGX 1.3M
  • TNET 472.0K
  • Earning Date
  • PTGX 11-06-2025
  • TNET 10-29-2025
  • Dividend Yield
  • PTGX N/A
  • TNET 1.99%
  • EPS Growth
  • PTGX N/A
  • TNET N/A
  • EPS
  • PTGX 0.72
  • TNET 2.65
  • Revenue
  • PTGX $209,217,000.00
  • TNET $4,971,000,000.00
  • Revenue This Year
  • PTGX N/A
  • TNET $2.49
  • Revenue Next Year
  • PTGX $140.23
  • TNET $3.17
  • P/E Ratio
  • PTGX $110.77
  • TNET $20.88
  • Revenue Growth
  • PTGX N/A
  • TNET N/A
  • 52 Week Low
  • PTGX $33.31
  • TNET $54.61
  • 52 Week High
  • PTGX $93.25
  • TNET $98.51
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 62.21
  • TNET 30.81
  • Support Level
  • PTGX $75.44
  • TNET $54.61
  • Resistance Level
  • PTGX $80.43
  • TNET $65.13
  • Average True Range (ATR)
  • PTGX 2.61
  • TNET 2.47
  • MACD
  • PTGX -0.23
  • TNET -0.46
  • Stochastic Oscillator
  • PTGX 89.38
  • TNET 6.32

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About TNET TriNet Group Inc.

Trinet Group Inc outsourced payroll and human capital management solutions for small and midsize businesses via a professional employer organization model. Under the PEO model, TriNet enters a co-employment arrangement and acts as the employer of record for administrative and regulatory purposes for clients' employees, known as worksite employees. Clients leverage the scale and expertise of TriNet to access competitive employee benefits, share employment risk liability, access compliance support, and outsource mission-critical day-to-day HR functions such as payroll and tax administration. Following the acquisition of Zenefits and Clarus R+D in 2022, TriNet derives the minority of its revenue from self-service HCM software and R&D tax credit services.

Share on Social Networks: